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Background. The present study was primarily designed to
assess the prevalence of chronic kidney disease in a Mexican
urban population residing in Mexico and to evaluate certain
biologic and socioeconomic conditions as risk factors for the
development of renal disease.
Methods. A population-based cross-sectional survey was con-
ducted, which included 3564 patients of either gender aged >18
years, who were randomly selected from lists of patients as-
signed to primary care facilities in the city of Morelia. A ques-
tionnaire about personal current health status, kidney disease,
diabetes, hypertension, or heart disease in close relatives, an-
thropometric and blood pressure measurements, and blood and
urine samples to measure glucose, blood urea nitrogen, and
creatinine was obtained for each patient. Creatinine clearance
(Ccr) was calculated by the Cockcroft-Gault formula. Patients
were classified in 1 of the 5 Ccr categories established by the
Kidney Disease Outcomes Quality Initiative guidelines.
Results. The prevalence rate of Ccr < 15 mL/min was 1142
per million population, and that of Ccr <60mL/min 80,788 per
million population. Alcohol and tobacco consumption, female
gender, age >65 years, educational level < primary school, and
income <US $4.00/day were significantly associated with re-
duced Ccr.
Conclusion. Chronic kidney disease prevalence in this popu-
lation is similar to that seen in industrialized countries. If these
figures are similar to those of the entire Mexican population,
only l out of 4 patients requiring renal replacement therapy in
the country currently has access to it.
Resumen
Antecedentes. El presente estudio se disen˜o´ primariamente
para determinar la prevalencia de la enfermedad renal cro´nica
(ERC) en una poblacio´n urbana de Me´xico y secundariamente
para evaluar algunas condiciones biolo´gicas y socioecono´micas
que pudieran ser factores de riesgo para el desarrollo de la
enfermedad renal.
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Me´todos. Se realizo´ un estudio transversal en una poblacio´n
que incluyo´ a 3,564 sujetos, de ambos ge´neros, con edad >18
an˜os, seleccionados al azar de los listados de las personas asig-
nadas a clı´nicas de atencio´n primaria en la ciudad de Morelia,
Me´xico. Se aplico´ un cuestionario a cada individuo, que incluı´a
su estado de salud actual y la presencia de enfermedad renal,
diabetes, hipertensio´n arterial o enfermedad vascular en famil-
iares cercanos; se tomaron adema´s en cada sujeto sus medidas
antropome´tricas y presio´n arterial, ası´ como muestras de san-
gre y orina para la determinacio´n de glucosa, nitro´geno ureico y
creatinina. La depuracio´n de creatinina (DCr) se calculo´ con la
fo´rmula de Cockcroft-Gault. Los sujetos se clasificaron en una
de las cinco categorı´as de DCr, de acuerdo a lo establecido por
las guı´as K/DOQI.
Resultados. La prevalencia de la DCR < 15 mL/min fue de
1,142 por millo´n de habitantes (pmh), en tanto que la DCr <
60 mL/min fue de 80,788 pmh. Los factores asociados a una
baja DCr fueron el consumo de tabaco y alcohol, el ge´nero
femenino, la edad >65 an˜os, una escolaridad menor al nivel
primario e ingresos econo´micos < $ 4.00 USD/dı´a.
Conclusio´n. La prevalencia de ERC en esta muestra es sim-
ilar a la reportada en paı´ses industrializados. Si estas cifras son
similares a la totalidad de la poblacio´n mexicana, solo 1 de 4 pa-
cientes que requieren terapia de reemplazo renal tienen acceso
a ella.
Chronic kidney disease (CKD) is a growing problem
all over the world. The incidence and prevalence rates of
CKD and end-stage renal disease (ESRD) have increased
steadily for the last 3 decades [1, 2], and the expendi-
tures that the care of these patients generates have also
grown [3]. In developed countries, knowledge about the
incidence and prevalence rates of ESRD requiring renal
replacement therapy (RRT) is obtained through national
registries. The numbers shown by registries in developed
countries are believed to be a very close estimation of the
burden of kidney disease, because opportune detection
and therapy are available and accessible to virtually all
patients who need them. In Mexico, there is no national
registry of renal patients. Thus, the knowledge about the
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epidemiology of CKD and ESRD is very limited. In a
Mexican survey of patients with ESRD treated with peri-
toneal dialysis at the Instituto Mexicano del Seguro So-
cial (IMSS) in 1992, the prevalence rate of patients on
peritoneal dialysis was 200 patients per million popula-
tion (pmp). This figure was considered to be very close
to the total number of patients in substitutive therapy for
ESRD, because in Mexico, at that time, peritoneal dialy-
sis was the therapeutic modality used for more than 91%
of the patients receiving RRT [4]. This prevalence rate is
strikingly different from the corresponding figures in the
United States and Japan, both with more than 1000 pmp,
and also lower than the prevalence rates reported from
Latin American countries such as Puerto Rico, Uruguay,
Argentina, or Chile [2]. It is accepted that surveillance
systems based on national registries may underestimate
real ESRD prevalence rates in some countries because
of treatment selection bias, and that this underestimation
may contribute to observed differences among various
countries [2]. The wide gap of prevalence rates seen in
patients receiving RRT between Mexico and other Latin
American countries suggests that the true prevalence rate
of ESRD in Mexico is importantly underestimated. Ad-
ditional information supporting this assumption comes
from studies performed in Mexican American popula-
tions in the United States. In these groups, the rate of
patients receiving RRT is higher than that in the white
American population [5]. Also, the increase in the ESRD
incidence rate in Mexican Americans is greater than that
in black or white Americans [6]. Because appropriate
Mexican registries of renal patients are lacking, an avail-
able alternative to estimate the prevalence rate of CKD
in Mexico is a population-based cross-sectional survey.
The primary objective of the present study is to assess
the prevalence of CKD in a Mexican urban population
residing in Mexico. The secondary objective is to evaluate
the role of certain biological conditions, such as ischemic
heart disease, hypertension, stroke, and diabetes mellitus
in close relatives, and certain socioeconomic conditions
such as age, gender, marital status, salaried job, income,
and educational level, as risk factors for the development
of renal disease.
METHODS
A population-based cross-sectional survey was con-
ducted. The protocol was approved by the research and
ethics committee of the Hospital General de Zona 1,
Morelia, of the IMSS. The city of Morelia in the Mexi-
can State of Michoacan was selected for the study. It has
600,000 inhabitants and average characteristics among
major Mexican cities regarding income [7], child mortal-
ity, access to health services, and prevalence of hyperten-
sion and diabetes [8]. Michoacan is located in the region
of Mexico that had the highest density of emigrants to
the United States.
The IMSS provides health care services to salaried
workers and their families. Each individual entitled to
receive these services is assigned to a primary health care
facility. There are 3 primary care facilities in the city of
Morelia. The study sample was randomly selected from
the list of patients assigned to each facility. The num-
ber of patients sampled from each facility was propor-
tional to the total number of patients assigned to them.
Only patients aged 18 years or older were considered.
The sampling was stratified by age and gender according
to the distribution of these variables in the city’s popula-
tion. Selected patients were contacted in their homes by
telephone call or personal visit, and invited to participate
in the study. If they accepted, an informed consent form
was signed. A scheduled visit was programmed to 1 out
of 3 data collection centers, where questionnaires were
administered, anthropometric and blood pressure mea-
surements were taken, and blood and urine samples were
collected. The sample size was calculated with a formula
for descriptive studies designed to find out a proportion
[9] and to meet the following criteria: a confidence level of
99%, acceptable error ±3%, and expected prevalence of
CKD 600 pmp. There were approximately 40,000 patients
aged 18 years or older in the lists. The calculated sample
size was 3961 patients; 397 (10.02%) were excluded be-
cause they were not found, refused to participate, or did
not show up for the scheduled visit. Therefore, the final
number of patients included in the sample was 3564. The
fieldwork was done from June 1999 to February 2000.
Surveyors were trained to uniformly administer the
questionnaire, take height, weight, and blood pressure
measurements, and perform blood and urine sampling.
The questionnaire included information about per-
sonal current health status, and presence of kidney dis-
ease, diabetes, hypertension, or heart disease in close
relatives.
Weight and height were measured while patients wore
light clothing and no shoes. With these data, body surface
area and body mass index were calculated with standard
formulas. Blood pressure was measured on 3 different
days from 8:00 to 10:00 AM, with the patient sitting after
5 minutes of rest with a mercury sphygmomanometer.
Systolic and diastolic blood pressure was considered as
Korotkoff’s phases I and V, respectively.
After patients fasted for 12 hours, a blood sample was
drawn from an antecubital vein for serum glucose, creati-
nine, and blood urea nitrogen, with automated equipment
(Synchron CX-5; Beckman, Brea, CA). From all known
patients with diabetes, heparinized blood aliquots were
stored to measure glycosilated hemoglobin (HbA1c) by
ionic exchange chromatography [10]. In a casual urine
sample, voided from 8:00 to 10:00 AM, a 11-reagents
dipstick test (Combur-test; Lakeside, Chicago, IL) was
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conducted and scored visually against a colored chart. In
addition, in patients with diabetes and/or hypertension
who had a normal dipstick test, microalbuminuria was as-
sessed by nephelometry (Array, Beckman) and corrected
by creatinine excretion.
Creatinine clearance (Ccr) was calculated by the
Cockcroft-Gault method [11]. Patients were classified in
1 of 5 strata of Ccr ≥ 90, 60 to 89, 30 to 59, 15 to 29, and
< 15 as established by the Kidney Disease Outcomes
Quality Initiative clinical practice guidelines for CKD
[12]. A patient was classified as diabetic when he or she
had been previously diagnosed as diabetic, was receiv-
ing insulin or oral hypoglycemic agents, or had a fasting
serum glucose level >126 mg/dL [13]. A patient was clas-
sified as hypertensive when he or she had been previously
diagnosed as hypertensive, was receiving antihyperten-
sive drugs, or the average of 3 blood pressure measure-
ments was >140 mm Hg for the systolic or >90 mm Hg
for the diastolic [14].
Statistical analysis
Data are presented as frequencies, percentages, or
mean ± standard deviation as appropriate. Intergroup
differences were assessed by v 2 test for nominal variables
and the Student t test for continuous variables. Multivari-
ate analyses were performed by logistic regression. All
statistical analyses were done with SPSS Version 8.0 for
Windows (Chicago, IL, USA).
RESULTS
Table 1 shows the actual distribution of 3564 patients
and estimated prevalence for each of the 5 Ccr strata.
The estimated prevalence rate of patients with Ccr ≥15
mL/min 1.73 m2 is 1143 pmp aged 18 years or older, with
a 95% confidence interval (CI) from 206 to 2078. Only
11.1% of patients with Ccr <60 mL/min were aware of
having renal disease, while 25% of the patients with Ccr
<15 mL/min knew they had kidney disease. On the other
hand, 208 patients reported having kidney disease, but
their Ccr levels were 90 mL/min and their urine dipstick
tests were normal. Being unaware of kidney disease was
not associated with educational level, income, or employ-
ment status. A comparison of the percentage of patients in
each Ccr strata for the present study and for the American
population, according to calculations done by the Kidney
Disease Outcomes Quality Initiatives group using the Na-
tional Health and Nutrition Examination Survey III data,
[12] is shown in Table 2.
The estimated prevalence of diabetes mellitus is 10.9%
(95% CI = 9.9–11.9). Less than half (48.6%) of the pa-
tients with diabetes were aware of having diabetes mel-
litus. The estimated prevalence of hypertension is 20.6%
(95% CI = 19.3–21.9), and 56.4% of the patients with hy-
Table 1. Distribution of 3564 studied patients and estimated
prevalence for each of 5 Ccr strata
Prevalence
Ccr (mL/min/1.73m2 BSA)a N (pmp)b 95% CI
≥90 2226 626,034 612,628–639,442
60–89 1034 289,181 276,618–301,744
30–59 290 80,788 73,237–88,339
15–29 10 2855 1367–4333
≤15 4 1142 206–2078
Total 3564 1,000,000
Abbreviations are: Ccr, creatinine clearance; BSA, body surface area; pmp,
per million population; 95%CI, 95% confidence interval.
aCalculated with the Cockroft-Gault formula [11].
bAge ≥18 years old.
Table 2. Comparison of the percentage of patients in each Ccr strata
for present study calculations done by the K/DOQI group
Ccr (mL/min/1.73 m2 BSA) Present study (%) K/DOQI (%)a
≥90 62.5 64.3
60–89 29.0 31.2
30–59 8.1 4.2
15–29 0.3 0.2
≤15 0.1 0.2
Abbreviations are: K/DOQI, Kidney Disease Outcomes Quality Initiatives;
Ccr, creatinine clearance; BSA, body surface area.
aPercentage of patients in each Ccr strata for the American population
according to calculations done by the K/DOQI group using the NHANES data
[12].
pertension were aware of having hypertension. Diabetes
mellitus was present in 25% of the patients with Ccr <60
mL/min and in 40% of the patients with Ccr <15 mL/min.
Hypertension was present in 34% of the patients with Ccr
<60 mL/min and in 58% of the patients with Ccr < 15
mL/min.
Proteinuria was detectable by dipstick in 8.7% of the
patients with Ccr ≥60 mL/min. In patients with diabetes
mellitus and hypertension, proteinuria was more fre-
quent (12.5%) and higher (0.35 ± 0.94 g/mg Cr) than
in patients with diabetes without hypertension (6.3%,
0.13 ± 2.0 g/mg Cr, P < 0.05). All patients with diabetes
with Ccr <60 mL/min had proteinuria. Only 2.8% of the
patients with hypertension without diabetes had protein-
uria. The patients with diabetes with Ccr <60 mL/min
and hypertension had higher levels of proteinuria
(0.72 ± 2.0 g/mg Cr) than the patients with diabetes with
Ccr <60 mL/min without hypertension (0.35 ± 2.0 g/mg
Cr, P < 0.05). In patients with diabetes, HbAlc was pos-
itively correlated with fasting glucose levels (r = 0.55,
P < 0.01), proteinuria (r = 0.20, P < 0.05), and microal-
buminuria (r = 0.19, P < 0.05). Only 2.7% of the patients
with hypertension with Ccr ≥60 mL/min had proteinuria,
and 4.7% of the patients with hypertension with Ccr ≥60
mL/min had microalbuminuria.
Patients with Ccr <60 mL/min had close relatives with
diabetes, hypertension, heart disease, and stroke more
frequently than patients with Ccr ≥60 mL/min (Table 3).
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Table 3. Association of CKD with ischemic heart disease,
hypertension, stroke, and diabetes mellitus in close relatives
Normal renal functiona CKD P value
Ischemic heart disease (father)
Yes 87 13 0.01
No 92 8
Ischemic heart disease (mother)
Yes 87 13 0.02
No 92 8
Hypertension (siblings)
Yes 86 14 0.01
No 92 8
Stroke (siblings)
Yes 80 20 0.01
No 92 8
Ischemic heart disease (siblings)
Yes 86 14 0.01
No 92 8
Diabetes mellitus (siblings)
Yes 84 16 0.01
No 92 8
aValues are shown as percentages; normal renal function, Ccr >60 mL/min.
Table 4. Logistic regression model including hypertension, ischemic
heart disease, stroke, and diabetes mellitus in siblings as risk factors
for CKD
OR 95% CI P value
Hypertension 1.4162 0.90–2.24 0.1331
Ischemic heart disease 101588 0.53–2.52 0.7102
Stroke 2.1576 0.93–5.00 0.0733
Diabetes mellitus 1.9681 1.34–2.90 0.0006
Abbreviations are: OR, odds ratio; 95%CI, 95% confidence interval.
P values < 0.05 were considered statistically significant.
However, when tested together in a regression model to
assess their role as independent risk factors for CKD, only
the presence of diabetes in siblings remained significantly
associated with a Ccr <60 mL/min (Table 4).
Alcohol (P < 0.01) and tobacco (P < 0.02) consump-
tion was significantly associated with a Ccr <60 mL/min.
Length of exposure to these substances was also signifi-
cantly longer in patients with Ccr <60 mL/min as com-
pared with that of patients with Ccr >60 mL/min (data
not shown). Being elderly, female, single, widowed, or
divorced, having a low educational level, being unem-
ployed, and having low income were significantly asso-
ciated with a Ccr <60 mL/min when tested separately
(Table 5). However, in a logistic regression model that
includes all of these variables together, only gender, age,
educational level, and income remained independent risk
factors for CKD (Table 6).
DISCUSSION
Our results show that this Mexican population living
in Mexico has prevalence rates of CKD similar to or
higher than those in developed countries with national
registries of renal patients. Diabetes and hypertension
Table 5. Association of CKD with age, gender, marital status,
educational level, employment, and income
Normal renal function CKD P value
Age (y)a 37.32 ± 12.83 63.12 ± 17.33 < 0.01
Gender
Male 96 4 < 0.01
Female 84 16
Educational level (<primary)
Yes 85 15 < 0.01
No 95 5
Salaried job
Yes 95 5 < 0.01
No 79 21
Spouse
Yes 93 7 < 0.01
No 66 34
Income (<USD $4.00/d)
Yes 79 21 < 0.01
No 95 5
All values are percentages except for age,a shown as mean ± standard
deviation; normal renal function, CCR >60 mL/min.
Table 6. Logistic regression model including spouse, salaried job,
income, educational level, age, and gender as risk factors for CKD
OR 95% CI P value
Spouse (yes) 0.9953 0.67–1.49 0.9815
Salaried job (yes) 1.2021 0.8–1.80 0.3706
Income (>USD $4.00/d) 0.5365 0.36–0.76 0.0004
Education (<primary) 1.9688 1.37–2.83 0.0003
Age (>65 y) 1.1158 1.10–1.13 0000
Gender (male) 0.3204 0.22–0.48 0000
Abbreviations are: OR, odds ratio; 95%CI, 95% confidence interval.
P values < 0.05 were considered statistically significant.
are important risk factors for renal function impairment.
The association of reduced renal function and the pres-
ence of diabetes and cardiovascular diseases in close rel-
atives suggest an important role for underlying genetic
factors in the development of renal disease. On the other
hand, the association of renal disease and certain social
and economic factors suggests that the lack of opportune
preventive health care interventions focused on risk fac-
tors may aggravate this problem.
The unawareness of hypertension in our sample
(43.6%) was lower than the figure recently reported by
Arroyo et al (72.0%) for urban Mexican population [15].
This difference may be explained by the fact that health
services are more available for patients of our sample
than for the general Mexican population. Unawareness
of diabetes in our sample was 51.3%. It is noteworthy that
unawareness of renal disease was strikingly high: 89.0%
of the patients with Ccr <60 mL/min and 75% of the pa-
tients with Ccr <15 mL/min did not know they had a renal
disease. The strategy to cope with this problem should be
directed to educational programs for primary care physi-
cians and other members of the health care team such as
nurses, nutritionists, and clinical laboratory staff. How-
ever, even in the United States, the wealthiest country in
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the world, there is concern that patients requiring RRT,
who represent only 0.8% of the Medicare population,
consume 5.2% of total Medicare expenditures. In Mex-
ico, the IMSS spends approximately 10% of its health
care budget to care for patients who require RRT. If the
present data reflect the picture in the whole country, no
more than 20% of patients who should receive RRT actu-
ally receive it. Mexican health care institutions may not be
able to support the heavy economic burden of providing
RRT for all patients who need it. Beyond the monetary
issue, there is lack of trained nephrologists and nephrol-
ogy nurses needed to care for these patients. It would take
many years to educate and train the required number of
such health care professionals. Currently, approximately
300 nephrologists are certified by the Mexican Board of
Nephrology (Consejo Mexicano de Nefrologia) in Mex-
ico. The current number of specialists is not enough to
care for patients requiring RRT, not to mention patients
with Ccr < 60 mL/min who could benefit from nephrol-
ogy consultation. [16, 17]. All Mexican parties interested
in these issues should begin to analyze different options
to cope with this impending problem.
High incidence and prevalence rates of renal disease
have been previously reported in Mexican Americans liv-
ing in the United States [4, 5, 18–23]. Diabetes plays a
major role in the development of renal disease. Diabetes
prevalence rate is as high as 25% in populations at the
low socioeconomic strata [24]. Our data show a lower fig-
ure for diabetes prevalence (10.9%); however, it is higher
than that reported for white Americans. The progression
rate of renal damage has been reported to be faster in
Mexican Americans than in white Americans [25], which
suggests a role for genetic and/or environmental factors.
Moreover, the presence of microalbuminuria is more fre-
quent in Mexican patients with diabetes or hypertension
than in their white American counterparts [26, 27].
Diabetic nephropathy accounts for 44% of Mexican
patients receiving RRT [4]. The fact that diabetes is more
frequent in Mexicans than in other ethnic groups may not
be the only explanation for this high figure, because in
our sample only 10.0% of patients with Ccr <15 mL/min,
and 25.2% of patients with Ccr <60 mL/min had diabetes
mellitus. Diabetes has been reported as a predictor for
early referral to a nephrologist [28], which suggests that
primary care physicians are more likely to recognize the
risk of renal disease in the setting of diabetes compared
with nondiabetic causes of renal failure.
The prevalence rate of hypertension in Mexican pa-
tients in this and other studies [29] is similar to that
reported for white Americans [30]. The lack of oppor-
tunity for diagnosis and treatment of hypertension plays
an important role in the development and progression of
renal damage, as has been previously reported [31, 32].
Patients with diabetes with hypertension showed a higher
frequency of proteinuria and also a higher level of urinary
protein excretion than patients with diabetes without hy-
pertension. Mexican Americans show higher cardiovas-
cular mortality rates than white Americans, which may
be partially explained by genetic factors related to hy-
pertension and heart disease. A study of Mexicans living
in San Antonio, Texas, suggested that there are genetic
factors related to obesity, lipid metabolism disorders,
and atherosclerosis in this group [33]. A direct relation-
ship between atherosclerosis and renal disease has not
been demonstrated. However, the association shown in
the present study between CKD and the presence of is-
chemic heart disease, stroke, and diabetes, may represent
a pathophysiologic link. This is particularly relevant for
the elderly, because it has been reported that vascular
damage may be responsible for loss of renal function in
the elderly [34].
It has been shown that tobacco consumption is a risk
factor for the progression of kidney disease in diabetic
nephropathy [35] and other renal diseases [36]. In the
present study, patients with CKD had a significantly
higher frequency of tobacco use and a longer exposure
time. The association of certain indices of poverty and a
Ccr <60 mL/min that we observed is not likely to repre-
sent a causal link. However, there are mechanisms that
may explain the effect of poverty and low educational
level on the development of CKD. Socially marginal
populations from many countries have been shown to
be more susceptible to renal disease [37–39]. Prematu-
rity and low birth weights are more prevalent at lower
socioeconomic levels and may be risk factors for CKD
[37, 40]. It has been shown in some studies that prema-
ture and low-birth-weight newborns have fewer nephrons
than term infants do, and that this lower nephron number
is associated in adult age with hyperfiltration and renal
damage [41]. In the present study sample, less than 10%
of the patients knew their birth weight and, therefore,
this factor could not be assessed. In Mexico, the prema-
turity rate is 10.2%, and 5.03% of term infants have a
birth weight <2,500 g; [8] therefore, this hypothesis is
plausible.
Poverty and low educational level may also predispose
to inadequate alimentary habits. In Mexican Americans
living in the United States the prevalence rate of obe-
sity is 50% and that of diabetes is 25%, figures that are
higher than those seen in many other ethnic groups [24,
42]. The prevalence rates of obesity and diabetes are
even higher for women in the poorest strata. In Mexico,
the prevalence rate of obesity is also very high, perhaps
due to inadequate nutritional habits. Mexican Americans
living in the United States are more reluctant to use high-
technology medicine, less compliant with chronic treat-
ments, and more willing to delegate the decisions about
health care and treatment to health care team members
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or relatives as compared with the white American pop-
ulation [43]. These practices may considerably delay di-
agnosis and treatment, and impair the quality of health
care for chronic diseases.
CONCLUSION
The prevalence rates of CKD and the need for RRT in
Mexico seem to be similar or higher compared to those
in industrialized countries. The high prevalence rate of
renal diseases may be partially explained by the higher
frequency of diabetes in Mexicans, but other genetic and
socioeconomic factors may also play a role.
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